Evidence map›Paper›PMID 33776903›Full record

ArticleFrontiers in endocrinology2021

Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.

Yesica Garciafigueroa, Brett E Phillips, Carl Engman, Massimo Trucco, Nick Giannoukakis

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. NETs: a new target for autoimmune disease.Frontiers in immunology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yesica GarciafigueroaInstitute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.
Brett E PhillipsInstitute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.
Carl EngmanInstitute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.
Massimo TruccoInstitute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.
Nick GiannoukakisInstitute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.
Allegheny Health Network · US

Funding

CXCR2 antagonism in the immunometabolic regulation of type 2 diabetesR21TR001728 · NCATS · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI GIANNOUKAKIS, NICK · 2016 to 2017
$643k
NCATS NIH HHS R21 TR001728
6 · The paper itself

Abstract

A growing body of evidence indicates that neutrophils are the first major leukocyte population accumulating inside the pancreas even before the onset of a lymphocytic-driven impairment of functional beta cells in type 1 diabetes mellitus (T1D). In humans, pancreata from T1D deceased donors exhibit significant neutrophil accumulation. We present a time course of previously unknown inflammatory changes that accompany neutrophil and neutrophil elastase accumulation in the pancreas of the non-obese diabetic (NOD) mouse strain as early as 2 weeks of age. We confirm earlier findings in NOD mice that neutrophils accumulate as early as 2 weeks of age. We also observe a concurrent increase in the expression of neutrophil elastase in this time period. We also detect components of neutrophil extracellular traps (NET) mainly in the exocrine tissue of the pancreas during this time as well as markers of vascular pathology as early as 2 weeks of age. Age- and sex-matched C57BL/6 mice do not exhibit these features inside the pancreas. When we treated NOD mice with inhibitors of myeloperoxidase and neutrophil elastase, two key effectors of activated neutrophil activity, alone or in combination, we were unable to prevent the progression to hyperglycemia in any manner different from untreated control mice. Our data confirm and add to the body of evidence demonstrating neutrophil accumulation inside the pancreas of mice genetically susceptible to T1D and also offer novel insights into additional pathologic mechanisms involving the pancreatic vasculature that have, until now, not been discovered inside the pancreata of these mice. However, inhibition of key neutrophil enzymes expressed in activated neutrophils could not prevent diabetes. These findings add to the body of data supporting a role for neutrophils in the establishment of early pathology inside the pancreas, independently of, and earlier from the time at onset of lymphocytic infiltration. However, they also suggest that inhibition of neutrophils alone, acting

Indexed as

Age FactorsAnimalsAnimals, NewbornAntigens, LyAutoantibodiesCitrullinationExtracellular TrapsFemaleGrowth and DevelopmentHistonesInflammationInsulin-Secreting CellsLeukocyte ElastaseMaleMembrane GlycoproteinsMiceAntigens, LyAutoantibodiesHistonesLeukocyte ElastaseLy6G antigen, mouseMembrane GlycoproteinsP-selectin ligand proteinautoimmunityAZD5904AZD9668myeloperoxidaseneutrophil elastaseneutrophilsnon-obese diabetes (NOD) micetype 1 diabetes

Identifiers

PMID33776903
PMCPMC7988208
OpenAlexW3134057175

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.